The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Oral Session (O173-O175) - Takeaways - MDSpire

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Oral Session (O173-O175)

  • November 9, 2023

  • 0 min

Share

  • 1

    The study analyzed patient-pharmacist interactions in allogeneic stem cell transplant recipients using an mHealth platform.

  • 2

    Pharmacists reviewed 297 drugs for 22 patients, with a 70.7% activation rate of the drugs introduced by patients.

  • 3

    Patients sent and received a total of 183 messages, indicating active communication between pharmacists and patients.

  • 4

    Pharmacist involvement improved medication management and communication, addressing non-urgent consultations effectively.

  • 5

    The study highlights the potential of mHealth tools in enhancing pharmaceutical care for allo-SCT patients.

Original Source(s)

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Oral Session (O173-O175)

  • November 9, 2023

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

A look at what pediatric hospitalists think of gender bias

Glycocalyx Biomarkers as Early Predictors of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Patients